Payment overview · 2025
General Payments
$24.66
1 reported records · 1 companies
Healthcare provider profile · identity verified
James Mcmullin, DO
Allopathic & Osteopathic Physicians|General Practice · SEARCY, AR · NPI 1972036457
Verified facts
What the public records show
CMS Open Payments records show James Mcmullin, DO received $24.66 in general payments during 2025 across 1 reported records.
Abbott Laboratories accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Abbott Laboratories | Unresolved — no canonical attribution shown | $24.66 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $24.66 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $24.66 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 596 | 209 |
| Levothyroxine Sodium | Levothyroxine Sodium | 516 | 149 |
| Lisinopril | Lisinopril | 347 | 119 |
| Tramadol Hcl | Tramadol Hcl | 333 | 78 |
| Metformin Hcl | Metformin Hcl | 324 | 84 |
| Gabapentin | Gabapentin | 313 | 102 |
| Amlodipine Besylate | Amlodipine Besylate | 308 | 106 |
| Tamsulosin Hcl | Tamsulosin Hcl | 301 | 86 |
| Losartan Potassium | Losartan Potassium | 290 | 80 |
| Omeprazole | Omeprazole | 286 | 95 |
| Potassium Chloride | Potassium Chloride | 285 | 83 |
| Furosemide | Furosemide | 261 | 80 |
| Metoprolol Succinate | Metoprolol Succinate | 260 | 70 |
| Pantoprazole Sodium | Pantoprazole Sodium | 241 | 74 |
| Eliquis | Apixaban | 230 | 50 |
| Trazodone Hcl | Trazodone Hcl | 212 | 67 |
| Tizanidine Hcl | Tizanidine Hcl | 204 | 63 |
| Carvedilol | Carvedilol | 186 | 54 |
| Clopidogrel | Clopidogrel Bisulfate | 179 | 48 |
| Allopurinol | Allopurinol | 158 | 51 |
| Duloxetine Hcl | Duloxetine Hcl | 155 | 46 |
| Hydrochlorothiazide | Hydrochlorothiazide | 154 | 48 |
| Ozempic | Semaglutide | 150 | 29 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 144 | 46 |
| Fluticasone Propionate | Fluticasone Propionate | 140 | 58 |
| Doxycycline Hyclate | Doxycycline Hyclate | 134 | 117 |
| Meloxicam | Meloxicam | 130 | 55 |
| Escitalopram Oxalate | Escitalopram Oxalate | 127 | 35 |
| Lorazepam | Lorazepam | 127 | 34 |
| Sertraline Hcl | Sertraline Hcl | 121 | 43 |
| Quetiapine Fumarate | Quetiapine Fumarate | 111 | 39 |
| Alprazolam | Alprazolam | 108 | 22 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 106 | 44 |
| Glipizide | Glipizide | 104 | 33 |
| Zolpidem Tartrate | Zolpidem Tartrate | 97 | 20 |
| Pravastatin Sodium | Pravastatin Sodium | 96 | 30 |
| Simvastatin | Simvastatin | 96 | 33 |
| Atenolol | Atenolol | 94 | 34 |
| Azithromycin | Azithromycin | 93 | 83 |
| Buspirone Hcl | Buspirone Hcl | 90 | 20 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 90 | 30 |
| Citalopram Hbr | Citalopram Hydrobromide | 87 | 23 |
| Jardiance | Empagliflozin | 86 | 18 |
| Pregabalin | Pregabalin | 86 | 16 |
| Diclofenac Sodium | Diclofenac Sodium | 84 | 38 |
| Donepezil Hcl | Donepezil Hcl | 80 | 21 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 80 | 25 |
| Metoprolol Tartrate | Metoprolol Tartrate | 79 | 38 |
| Famotidine | Famotidine | 77 | 24 |
| Montelukast Sodium | Montelukast Sodium | 75 | 28 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 74 | 43 |
| Naproxen | Naproxen | 73 | 31 |
| Xarelto | Rivaroxaban | 72 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 70 | 19 |
| Azelastine Hcl | Azelastine Hcl | 66 | 34 |
| Pioglitazone Hcl | Pioglitazone Hcl | 66 | 21 |
| Clonazepam | Clonazepam | 65 | 15 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 65 | 24 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 65 | 21 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 63 | 56 |
| Finasteride | Finasteride | 63 | 24 |
| Mirtazapine | Mirtazapine | 62 | 23 |
| Fluoxetine Hcl | Fluoxetine Hcl | 58 | 18 |
| Oxybutynin Chloride | Oxybutynin Chloride | 57 | suppressed |
| Nifedipine Er | Nifedipine | 54 | 18 |
| Ezetimibe | Ezetimibe | 53 | 17 |
| Ondansetron Odt | Ondansetron | 52 | 36 |
| Risperidone | Risperidone | 52 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 51 | 13 |
| Metformin Hcl Er | Metformin Hcl | 51 | 23 |
| Mounjaro | Tirzepatide | 51 | suppressed |
| Celecoxib | Celecoxib | 50 | 13 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 50 | 16 |
| Fenofibrate | Fenofibrate | 49 | 16 |
| Sucralfate | Sucralfate | 49 | 14 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 48 | 11 |
| Cefdinir | Cefdinir | 47 | 41 |
| Cephalexin | Cephalexin | 47 | 39 |
| Januvia | Sitagliptin Phosphate | 47 | suppressed |
| Spironolactone | Spironolactone | 47 | 20 |
| Hydralazine Hcl | Hydralazine Hcl | 46 | 12 |
| Alendronate Sodium | Alendronate Sodium | 44 | 15 |
| Acyclovir | Acyclovir | 43 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 43 | 19 |
| Glipizide Er | Glipizide | 43 | 12 |
| Levetiracetam | Levetiracetam | 43 | suppressed |
| Methocarbamol | Methocarbamol | 41 | 20 |
| Diazepam | Diazepam | 40 | 12 |
| Memantine Hcl | Memantine Hcl | 40 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 40 | 13 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 39 | 22 |
| Carbamazepine | Carbamazepine | 38 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 37 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 37 | 14 |
| Prednisone | Prednisone | 36 | 29 |
| Paroxetine Hcl | Paroxetine Hcl | 35 | 13 |
| Chlorthalidone | Chlorthalidone | 34 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 33 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 32 | suppressed |
| Torsemide | Torsemide | 32 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 31 | suppressed |
| Glimepiride | Glimepiride | 30 | 11 |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 29 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 29 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 29 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 29 | 11 |
| Estradiol | Estradiol | 28 | suppressed |
| Linzess | Linaclotide | 28 | suppressed |
| Baclofen | Baclofen | 27 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 27 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 27 | 23 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 26 | 24 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 26 | suppressed |
| Fluconazole | Fluconazole | 26 | 23 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 26 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 26 | suppressed |
| Topiramate | Topiramate | 26 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 26 | 11 |
| Levofloxacin | Levofloxacin | 25 | 22 |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 24 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 24 | 20 |
| Warfarin Sodium | Warfarin Sodium | 23 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 22 | suppressed |
| Novolog | Insulin Aspart | 22 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 22 | suppressed |
| Aripiprazole | Aripiprazole | 21 | suppressed |
| Colchicine | Colchicine | 21 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 21 | suppressed |
| Primidone | Primidone | 21 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 21 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 21 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 20 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 20 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 20 | suppressed |
| Ranolazine Er | Ranolazine | 20 | suppressed |
| Bumetanide | Bumetanide | 19 | suppressed |
| Bupropion Xl | Bupropion Hcl | 19 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 19 | suppressed |
| Entresto | Sacubitril/Valsartan | 18 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 18 | suppressed |
| Methylprednisolone | Methylprednisolone | 18 | 18 |
| Trulicity | Dulaglutide | 18 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 16 | suppressed |
| Ibuprofen | Ibuprofen | 16 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 16 | suppressed |
| Latanoprost | Latanoprost | 16 | suppressed |
| Lovastatin | Lovastatin | 16 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 16 | 12 |
| Ondansetron Hcl | Ondansetron Hcl | 16 | 12 |
| Propranolol Hcl Er | Propranolol Hcl | 16 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 16 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 15 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 15 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 14 | 12 |
| Divalproex Sodium Er | Divalproex Sodium | 14 | suppressed |
| Synthroid | Levothyroxine Sodium | 14 | suppressed |
| Glyburide-Metformin Hcl | Glyburide/Metformin Hcl | 13 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 12 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 12 | suppressed |
| Dupixent Syringe | Dupilumab | 12 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 12 | suppressed |
| Haloperidol | Haloperidol | 12 | suppressed |
| Norethindrone Acetate | Norethindrone Acetate | 12 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 12 | suppressed |
| Olanzapine | Olanzapine | 12 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 12 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 12 | 12 |
| Sumatriptan Succinate | Sumatriptan Succinate | 12 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 12 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Admelog | Insulin Lispro | 11 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 11 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 11 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 11 | suppressed |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 11 | suppressed |
| Folic Acid | Folic Acid | 11 | suppressed |
| Humalog | Insulin Lispro | 11 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 11 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl/Pf | 11 | suppressed |
| Nitroglycerin | Nitroglycerin | 11 | suppressed |
| Nystatin | Nystatin | 11 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 11 | 11 |
| Vilazodone Hcl | Vilazodone Hcl | 11 | suppressed |
| Xigduo Xr | Dapaglifloz Propaned/Metformin | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $24.66 · 1 records | Abbott Laboratories | FREESTYLE LIBRE 3 | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error